alexa Paramjeet Kaur | U.S. Food and Drug Administration
ISSN: 0975-0851

Journal of Bioequivalence & Bioavailability
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Paramjeet Kaur

Paramjeet Kaur Paramjeet Kaur
Division of Bioequivalence II
U.S. Food and Drug Administration

Paramjeet Kaur is a Senior Reviewer at the Division of Bioequivalence II, Office of Generic Drugs, CDER, FDA. She reviews the bioequivalence studies, in vitro dissolution data, and bioanalytical method validations submitted in support of approval of generic drug applications. She has also written several bioequivalence study design recommendations for specific drug products. She received her Bachelor in Pharmacy from the Banaras Hindu University, India, and Doctorate in Industrial Pharmacy from St. John’s University, USA. Her current research interests include pharmacokinetics, use of pharmacokinetic modeling and simulation to
predict bioequivalence, and in-vitro in-vivo correlations.

Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version